Literature DB >> 6196763

Indomethacin alters the effects of substance-P and VIP on isolated airway smooth muscle.

J F Regal, D E Johnson.   

Abstract

Both substance-P and vasoactive intestinal peptide (VIP) have previously been demonstrated to contract and relax, respectively, the isolated guinea pig trachea. In addition, substance-P and VIP have been localized within the pulmonary innervation of various species. In the present studies, substance-P was found to cause a concentration-related contraction of isolated lung parenchymal strips of the guinea pig, as well as isolated tracheal strips. VIP caused a significant concentration-related relaxation of the isolated tracheal strip, but not the lung parenchymal strip. Indomethacin, a prostaglandin synthetase inhibitor, potentiated the contractile response of the trachea to substance-P and inhibited the VIP- and isoproterenol-induced relaxation. These studies are potentially important in understanding the pathogenesis of bronchospastic disorders, since alterations in prostaglandin biosynthesis may result in hyperreactivity of airways to contractile agonists such as neurotransmitters, as well as an inhibition of relaxation induced by endogenous substances such as VIP or beta agonists.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196763     DOI: 10.1016/0196-9781(83)90065-7

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Neutral endopeptidase-like enzyme controls the contractile activity of substance P in guinea pig lung.

Authors:  N P Stimler-Gerard
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

2.  Calcitonin gene-related peptide immunoreactivity in airway epithelial cells of the human fetus and infant.

Authors:  D E Johnson; J D Wobken
Journal:  Cell Tissue Res       Date:  1987-12       Impact factor: 5.249

3.  Epithelium-dependent effect of L-glutamate on airways: involvement of prostaglandins.

Authors:  Apostolia A Hatziefthimiou; Konstantinos I Gourgoulianis; Paschalis-Adam Molyvdas
Journal:  Mediators Inflamm       Date:  2002-02       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.